News
WBA
17.31
+0.29%
0.05
Walgreens Boots Alliance: Don't Be Duped - Beware Of A Value Trap
Walgreens Boots Alliance faces significant business challenges and has no easy solutions. Wall Street remains skeptical about Walgreens' ability to overcome its immense challenges. I urge investors to be cautious about its so-called "cheap" valuation. WBA stock is more indicative of a value trap than a value play.
Seeking Alpha · 12h ago
Wall Street's Most Accurate Analysts' Views On 3 Risk Off Stocks With Over 3% Dividend Yields
These are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector. Cal-Maine Foods, Inc., Altria Group and Walgreens Boots Alliance are among the stocks with the highest yields. Benzinga readers can review the latest analyst takes on their favorite stocks.
Benzinga · 13h ago
Walgreens: Waiting To See If New Medicine Works
Seeking Alpha · 1d ago
Walgreens: Hold Tight, Let It Turn Around First
Walgreens Boots Alliance is in the midst of a turnaround. In the last decade, WBA shares dropped from over $70 to less than $20. The company's quarterly dividend was nearly cut in half. New CEO Tim Wentworth has an eye to unlocking WBA's hidden potential.
Seeking Alpha · 1d ago
Weekly Report: what happened at WBA last week (0429-0503)?
Weekly Report · 1d ago
Where Is Zebra Technologies Leading the Retail Herd in 2024?
Zebra Technologies sees early signs of recovery in the retail sector. In Q1 2024, Zebra's revenue dipped 16% year-over-year to $1.2 billion. CEO Bill Burns says the company is seeing signs of growth in retail. The retail sector is a leading indicator of secular trends in the broader economy.
The Motley Fool · 2d ago
Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
Walgreens Boots Alliance, Inc. Has US$9.47b of debt on its balance sheet. The company's EBITDA fell 34% in the last 12 months. Its debt is more of a burden than it appears, but the company has plenty of cash to pay it off. The future profitability of the business will decide if Walgreens Boots is a good investment. Walgreen's Boots Alliance's debt is a concern to shareholders.
Simply Wall St · 2d ago
CVS Health: A Terrible Earnings Report, But An Undervalued Stock
CVS Health reported dismal earnings on May 1st, resulting in the largest one-day drop in the company's history. The stock price of CVS Health was down 17% after the report. The company is at a compelling valuation, but the stock is a HOLD for the long-term.
Seeking Alpha · 3d ago
DXYZ And The Fakers Dozen, 13 Stocks With Huge Downside Risk
Traditional investment strategies are no longer effective in modern markets. Algorithms make investing more like a voting machine. Most buy ratings are unreliable. The market doesn't care what investors think. Investing has gone mainstream in a way long-termers could never have imagined.
Seeking Alpha · 4d ago
I'm Buying The Dip With Up To 7% Yield
Enterprise Products Partners offers a 7% yield and has strong fundamentals, including a well-covered distribution and positive outlook. CVS Health has a 5% yield but has experienced a dip in price after reporting first quarter earnings. The healthcare giant's stock has been punished for higher medical utilization, but its business is growing.
Seeking Alpha · 4d ago
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
NASDAQ · 5d ago
The stock market is becoming a picnic for the bears
MarketWatch · 5d ago
Noteworthy Thursday Option Activity: WBA, CF, GOOGL
NASDAQ · 5d ago
Walgreens, Boehringer Ingelheim Partner To Improve Diversity In Clinical Trials
Benzinga · 5d ago
WALGREENS AND BOEHRINGER INGELHEIM ARE PARTNERING TO IMPROVE DIVERSITY IN CLINICAL TRIALS
Reuters · 5d ago
WALGREENS BOOTS ALLIANCE PROVIDES SUMMARY NOTICE OF PENDING AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE ACTION
Reuters · 6d ago
Walgreens Boots Alliance Nears Shareholder Suit Settlement
TipRanks · 6d ago
Investor Optimism Dampens as Walgreens Boots Alliance Struggles With Market Turbulence
Walgreens Boots Alliance Inc. (NASDAQ:WBA) shares plummeted by 18% in April, nearing a 26-year low. The drugstore chain's stock value has dropped nearly 50% in the past five years. Walgreens is facing tough times as it struggles with high debt stemming from aggressive acquisition spree. The company is embarking on a strategic review of its operations to regain investor confidence.
Benzinga · 6d ago
Rates Staying Higher for Longer Could Mean More Big Goodwill Write-Downs Ahead
Interest rates are forcing more companies to write down goodwill impairments. Walgreens Boots Alliance, Verizon Communications have taken some of the largest impairments of the past year. Interest rates are expected to remain higher for longer than expected. The biggest known impairment so far this year is $12.4 billion for Walgreen's.
The Wall Street Journal · 6d ago
Walmart is closing down its health centers. What’s that mean for Amazon, Walgreens and CVS?
MarketWatch · 6d ago
More
Webull provides a variety of real-time WBA stock news. You can receive the latest news about Walgreen Boots through multiple platforms. This information may help you make smarter investment decisions.
About WBA
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.